000 01309 a2200325 4500
005 20250517093102.0
264 0 _c20170403
008 201704s 0 0 eng d
022 _a1432-1262
024 7 _a10.1007/s00384-016-2593-7
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLi, Xiang
245 0 0 _aDual VEGF/EGFR inhibition versus single targeted agent treatment in patients with metastatic colorectal cancer: a meta-analysis of randomized trials.
_h[electronic resource]
260 _bInternational journal of colorectal disease
_cSep 2016
300 _a1655-6 p.
_bdigital
500 _aPublication Type: Letter; Meta-Analysis
650 0 4 _aAntineoplastic Agents
_xpharmacology
650 0 4 _aColorectal Neoplasms
_xdrug therapy
650 0 4 _aErbB Receptors
_xantagonists & inhibitors
650 0 4 _aHumans
650 0 4 _aMolecular Targeted Therapy
650 0 4 _aRandomized Controlled Trials as Topic
650 0 4 _aVascular Endothelial Growth Factor A
_xantagonists & inhibitors
650 0 4 _aWithholding Treatment
700 1 _aWang, Min
700 1 _aLiu, Gui-Yang
700 1 _aMa, Jian-Li
773 0 _tInternational journal of colorectal disease
_gvol. 31
_gno. 9
_gp. 1655-6
856 4 0 _uhttps://doi.org/10.1007/s00384-016-2593-7
_zAvailable from publisher's website
999 _c25973111
_d25973111